Home / Investors / Startups / Capsida

Capsida

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.

About Capsida

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.

Industries

Investors in Capsida (3)